A
EVAR

Abingworth’s Lombard Medical, Inc. EVAR Stock Holding History

Abingworth’s Portfolio EVAR Stock Details EVAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,473,452
Closed -$399K – 18
2017
Q4 		$399K Hold
3,473,452
– – 0.29% 17
2017
Q3 		$1.53M Hold
3,473,452
– – 1.06% 17
2017
Q2 		$1.81M Hold
3,473,452
– – 1.44% 11
2017
Q1 		$2.71M Hold
3,473,452
– – 2.02% 8
2016
Q4 		$2.03M Hold
3,473,452
– – 1.7% 9
2016
Q3 		$3.2M Hold
3,473,452
– – 3.07% 9
2016
Q2 		$3.79M Hold
3,473,452
– – 3.96% 7
2016
Q1 		$3.75M Hold
3,473,452
– – 3.49% 9
2015
Q4 		$4.45M Hold
3,473,452
– – 2.68% 8
2015
Q3 		$12.3M Hold
3,473,452
– – 7.2% 5
2015
Q2 		$15.1M Hold
3,473,452
– – 6.86% 5
2015
Q1 		$13.2M Hold
3,473,452
– – 5.61% 8
2014
Q4 		$22.1M Buy
3,473,452
+120,908
+4% +$793K 6.26% 6
2014
Q3 		$25.6M Buy
+3,352,544
New +$22.2M 15.33% 2

Abingworth's EVAR Position: Q1 2018 in Review

Abingworth sold out of Lombard Medical, Inc. (EVAR) in Q1 2018, closing a stake of 3,473,452 shares — an estimated $399K sold.

Abingworth first reported a position in EVAR in Q3 2014 and held it in 14 quarters. The position peaked at $25.6M in Q3 2014. 0 funds tracked by Wall St. Rank hold EVAR as of Q1 2018.

  • Abingworth reported no remaining Lombard Medical, Inc. position as of Q1 2018 after selling out during the quarter.
  • Abingworth sold 3,473,452 Lombard Medical, Inc. shares in Q1 2018, an estimated $399K.
  • Abingworth first reported a position in Lombard Medical, Inc. in Q3 2014 and held it in 14 quarters.
  • Abingworth's Lombard Medical, Inc. position peaked at $25.6M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q1 2018.

Based on Abingworth's 13F filing for Q1 2018, filed 15 May 2018.